1. Home
  2. ENTA vs ELMD Comparison

ENTA vs ELMD Comparison

Compare ENTA & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTA
  • ELMD
  • Stock Information
  • Founded
  • ENTA 1995
  • ELMD 1992
  • Country
  • ENTA United States
  • ELMD United States
  • Employees
  • ENTA N/A
  • ELMD N/A
  • Industry
  • ENTA Biotechnology: Pharmaceutical Preparations
  • ELMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • ENTA Health Care
  • ELMD Health Care
  • Exchange
  • ENTA Nasdaq
  • ELMD Nasdaq
  • Market Cap
  • ENTA 164.6M
  • ELMD 172.2M
  • IPO Year
  • ENTA 2013
  • ELMD 2010
  • Fundamental
  • Price
  • ENTA $7.51
  • ELMD $18.65
  • Analyst Decision
  • ENTA Buy
  • ELMD Strong Buy
  • Analyst Count
  • ENTA 5
  • ELMD 1
  • Target Price
  • ENTA $18.40
  • ELMD $29.00
  • AVG Volume (30 Days)
  • ENTA 173.3K
  • ELMD 62.8K
  • Earning Date
  • ENTA 08-08-2025
  • ELMD 08-26-2025
  • Dividend Yield
  • ENTA N/A
  • ELMD N/A
  • EPS Growth
  • ENTA N/A
  • ELMD 60.99
  • EPS
  • ENTA N/A
  • ELMD 0.79
  • Revenue
  • ENTA $64,462,999.00
  • ELMD $61,439,000.00
  • Revenue This Year
  • ENTA N/A
  • ELMD $17.91
  • Revenue Next Year
  • ENTA $2.75
  • ELMD $11.70
  • P/E Ratio
  • ENTA N/A
  • ELMD $23.57
  • Revenue Growth
  • ENTA N/A
  • ELMD 14.85
  • 52 Week Low
  • ENTA $4.09
  • ELMD $13.74
  • 52 Week High
  • ENTA $15.92
  • ELMD $35.56
  • Technical
  • Relative Strength Index (RSI)
  • ENTA 51.19
  • ELMD 41.28
  • Support Level
  • ENTA $7.15
  • ELMD $18.47
  • Resistance Level
  • ENTA $8.31
  • ELMD $19.21
  • Average True Range (ATR)
  • ENTA 0.48
  • ELMD 0.60
  • MACD
  • ENTA 0.01
  • ELMD 0.05
  • Stochastic Oscillator
  • ENTA 55.73
  • ELMD 46.26

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

About ELMD Electromed Inc.

Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.

Share on Social Networks: